Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer

BMC Cancer(2021)10.1186/s12885-021-08573-2Source: DataRank Database

A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer is a research paper published in BMC Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.71)OA: goldTopics (77)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Bruna M. Sugita ORCID,Paolo Fadda ORCID,Rafael Marchi ORCID,Ali Afsari,Tammey Naab ORCID

Live enrichment

PubMed:34315420 PMC:PMC8317413 OpenAlex:https://openalex.org/W3122011545

NCI NIH HHS

Grant: P30 CA051008

NIMHD NIH HHS

Grant: U54 MD007597

NCI NIH HHS

Grant: P30 CA016058

National Institutes of Health

Grant: 3P30CA051008-16S1

CANCER CENTER SUPPORT GRANT

National Institutes of Health

Grant: 3P30CA016058-15S1

CORE--HORMONE RECEPTOR LABORATORY

FWCI

0.71

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2026

goldLicense: cc-by

journalhttps://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-021-08573-2

publisherhttps://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-021-08573-2

publisherhttps://link.springer.com/content/pdf/10.1186/s12885-021-08573-2.pdf

publisherhttps://link.springer.com/article/10.1186/s12885-021-08573-2/fulltext.html

journalhttps://doi.org/10.1186/s12885-021-08573-2

Fields of Study

MicroRNA in disease regulationCircular RNAs in diseasesBiological Research and Disease Studies03 medical and health sciences0302 clinical medicineAdultBlack or African AmericanAgedBiomarkers, TumorComputational BiologyFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateMicroRNAsMiddle AgedPrognosisRNA InterferenceRNA, MessengerROC CurveTriple Negative Breast Neoplasms

MeSH Terms

AdultAgedBlack or African AmericanFemaleHumansMiddle AgedPrognosisRNA, MessengerROC CurveBiomarkers, TumorGene Expression Regulation, NeoplasticComputational BiologyGene Expression ProfilingRNA InterferenceMicroRNAsKaplan-Meier EstimateTriple Negative Breast Neoplasms

Keywords

microRNASurgical oncologyBreast cancerTriple-negative breast cancerMedicineReceiver operating characteristicCancerOncologyMetastasisCancer researchInternal medicineSurvival analysisBiologyGeneGeneticsPrognosisLymph NodeTumor SizeAfrican-americanAdultTriple Negative Breast NeoplasmsKaplan-Meier EstimateBiomarkers, TumorHumansRNA, MessengerRC254-282AgedResearchGene Expression ProfilingNeoplasms. Tumors. Oncology. Including cancer and carcinogensComputational BiologyMiddle AgedBlack or African AmericanGene Expression Regulation, NeoplasticMicroRNAsROC CurveFemaleRNA Interference

Sustainable Development Goals

SDG 3: 3. Good healthSDG 10: 10. No inequalitySDG 0: Reduced inequalities

A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer

FAIR Checklist

Authors (11)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)